Thrombectomy Devices Market By Technology (Mechanical Thrombectomy, Aspiration Thrombectomy, Rheolytic Thrombectomy), By Type (Automated Devices, Manual Devices), By Utility (Reusable Devices, Disposable Devices), By Application (Peripheral Diseases, Coronary Disease, Neural Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global thrombectomy device market was valued at $1,269.0 million in 2020, and is projected to reach $2,567.5 million by 2030, registering a CAGR of 7.4% from 2021 to 2030. Thrombectomy device is used to treat blood clots, which are present in capillaries, veins, and arteries. Surgical thrombectomy is a procedure, which removes blood clot from an artery or vein that obstructs blood flow. Thrombectomy devices minimize the damage that can be caused to blood vessels during procedure and reduce blood loss. These devices are available according to affected areas, in different sizes, and diameters. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.
The key factors that drive the market growth include, increase in incidence of cardiovascular disease, rise in unhealthy living conditions and habits in young generation, and surge in geriatric population. Increase in incidence of neurological disorder, surge in demand for minimally invasive procedures, development of healthcare infrastructure, and rise in competition among key player for development of thrombectomy device propel the growth of the market. In addition, increase in technological advancements and innovations for development of advanced thrombectomy device surge the growth of the market.
Thrombectomy devices market is segmented on the basis of technology, type, utility, disease, and region. Depending on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. By type, it is divided into automated devices and manual devices. According to utility, it is bifurcated into reusable devices and disposable devices. As per disease, it is categorized into peripheral diseases, coronary diseases, and neural diseases
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include AngioDynamics, Inc., Johnson & Johnson, Inc., Penumbra Inc., Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc., Stryker Corporation, and Teleflex Incorporated
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the thrombectomy devices market analysis from 2020 to 2030 to identify the prevailing thrombectomy devices market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the thrombectomy devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global thrombectomy devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technology
Mechanical Thrombectomy
Aspiration Thrombectomy
Rheolytic Thrombectomy
By Type
Automated Devices
Manual Devices
By Utility
Reusable Devices
Disposable Devices
By Application
Peripheral Diseases
Coronary Disease
Neural Diseases
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Australia
Rest Of Asia Pacific
China
Japan
India
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
AngioDynamics, Inc
Boston Scientific Group
Johnson and Johnson
Koninklijke Philips N.V.
Medtronic plc
Penumbra Inc.
Stryker Corporation
Teleflex Incorporated
Terumo Corporation
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook